More than 40% of the world’s population have functional gastrointestinal disorders such as irritable bowel syndrome and functional constipation, among others. These disorders are associated with significant global healthcare costs, impaired health-related quality of life, and more frequent visits to physicians.¹

Viatris Inc has a strong and long heritage across the world providing access to medicines for people suffering from many gastrointestinal disorders, such as constipation or irritable bowel syndrome, and associated gastro diseases, such as pancreatic exocrine insufficiency.^1-2